Newsmax TV & Webwww.newsmax.comFREE - In Google Play
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
Tags: avastin | breast cancer | side effects | bevacizumab | chemotherapy

Avastin: Side Effects of the Breast Cancer Drug

Thursday, 09 January 2014 06:05 PM EST

How effective cancer therapy is, is judged by how long patients survive their cancer after diagnosis. And, also on how long the patient survives before the tumor metastasizes. Traditionally, the overall survival rate has been the standard used for measuring the efficiency of cancer therapy. Avastin is a drug that is used to cure cancer by targeting specific proteins on the surface of cells. The proteins attacked by Avastin actually helps cancer cell develop a new blood supply, and this is exactly what Avastin cuts off.

Avastin (bevacizumab) is used in chemotherapy and breast cancer treatment. Avastin (bevacizumab) is used to treat certain tumors and cancers of the breast, lung, rectum, colon, and kidney. Avastin is usually given along with a combination of other cancer treatment medications and chemotherapy. There are some side effects associated with bevacizumab medications.

Side Effects of Using Avastin (Bevacizumab) for Breast Cancer Treatment
Some of the common side effects of using Avastin (bevacizumab) include dry mouth, sweating, dizziness, coughing, loss of appetite, diarrhea, vomiting, constipation, mouth sores, headache. nausea, change in voice, flaky skin, pain in jaws, numbness and swelling in the mouth, loosening of teeth, and back pain.
Avastin may also cause certain other serious side effects when used to treat breast cancer. Some of the severe side effects noticed thus far include neurological disorders, vision problems, and convulsions and blackout. Usually, such severe side effects are noticed at the beginning of chemotherapy and when Avastin (bevacizumab) is administered for the first time for breast cancer treatment. If these side effects are not caused, they generally do not appear up to a year of having taken Avastin.
Avastin (bevacizumab) is administered as an injection while treating breast cancer. Certain side effects may be caused at the site of injection. They are itching; rash; fever; nausea; difficulty in breathing; and swelling of the tongue, lips, throat, and face. Sweating, dizziness, wheezing, and chest pain may also be noticed as side effects in some after Avastin (bevacizumab) has been injected.
Some breast cancer patients have also complained of the following after the administration of Avastin for breast cancer treatment: abnormal urination, abnormal weight loss or gain, watery eyes, vaginal discharge, flulike symptoms, blood in stool, and dangerously high blood pressure. 

If any of these side effects persist, be sure to check with your doctor regarding Avastin (bevacizumab) administration for treating breast cancer.

© Newsmax. All rights reserved.

Breast cancer is a leading disease in the U.S. that affects many women. Some medications such as Avastin (bevacizumab) are used in breast cancer treatment and chemotherapy. However, many side effects have been noted with Avastin administration that you need to know before taking treatment.
avastin,breast cancer,side effects,bevacizumab,chemotherapy
Thursday, 09 January 2014 06:05 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
You May Also Like
Get Newsmax Text Alerts

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved
© Newsmax Media, Inc.
All Rights Reserved